How a big FDA review of sunscreen ingredients is prompting industry lobbying

With two months to go before a key date for its major review of sunscreens, the Food and Drug Administration says it’s considering requests from manufacturers to delay some rulemaking.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.